genmed commercial finance limited Company Information
Company Number
02426578
Next Accounts
Sep 2025
Shareholders
general mediterranean holding (uk) ltd
arif husain
Group Structure
View All
Industry
Other financial service activities, except insurance and pension funding, (not including security dealing on own account and factoring) n.e.c.
Registered Address
lincoln house, 137-143 hammersmith road, london, W14 0QL
Website
http://gmhsa.comgenmed commercial finance limited Estimated Valuation
Pomanda estimates the enterprise value of GENMED COMMERCIAL FINANCE LIMITED at £4.4m based on a Turnover of £5.1m and 0.86x industry multiple (adjusted for size and gross margin).
genmed commercial finance limited Estimated Valuation
Pomanda estimates the enterprise value of GENMED COMMERCIAL FINANCE LIMITED at £0 based on an EBITDA of £-15m and a 2.98x industry multiple (adjusted for size and gross margin).
genmed commercial finance limited Estimated Valuation
Pomanda estimates the enterprise value of GENMED COMMERCIAL FINANCE LIMITED at £0 based on Net Assets of £-19.8m and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Genmed Commercial Finance Limited Overview
Genmed Commercial Finance Limited is a live company located in london, W14 0QL with a Companies House number of 02426578. It operates in the financial intermediation not elsewhere classified sector, SIC Code 64999. Founded in September 1989, it's largest shareholder is general mediterranean holding (uk) ltd with a 100% stake. Genmed Commercial Finance Limited is a mature, mid sized company, Pomanda has estimated its turnover at £5.1m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Genmed Commercial Finance Limited Health Check
Pomanda's financial health check has awarded Genmed Commercial Finance Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs


4 Strong

2 Regular

4 Weak

Size
annual sales of £5.1m, make it in line with the average company (£5.6m)
- Genmed Commercial Finance Limited
£5.6m - Industry AVG

Growth
3 year (CAGR) sales growth of 27%, show it is growing at a faster rate (4.9%)
- Genmed Commercial Finance Limited
4.9% - Industry AVG

Production
with a gross margin of 13.6%, this company has a higher cost of product (54%)
- Genmed Commercial Finance Limited
54% - Industry AVG

Profitability
an operating margin of -296% make it less profitable than the average company (9.1%)
- Genmed Commercial Finance Limited
9.1% - Industry AVG

Employees
with 9 employees, this is below the industry average (14)
- Genmed Commercial Finance Limited
14 - Industry AVG

Pay Structure
on an average salary of £82.9k, the company has an equivalent pay structure (£82.9k)
- Genmed Commercial Finance Limited
£82.9k - Industry AVG

Efficiency
resulting in sales per employee of £563.1k, this is more efficient (£223.8k)
- Genmed Commercial Finance Limited
£223.8k - Industry AVG

Debtor Days
it gets paid by customers after 0 days, this is earlier than average (33 days)
- Genmed Commercial Finance Limited
33 days - Industry AVG

Creditor Days
its suppliers are paid after 1649 days, this is slower than average (46 days)
- Genmed Commercial Finance Limited
46 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Genmed Commercial Finance Limited
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Genmed Commercial Finance Limited
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 620610%, this is a higher level of debt than the average (71.4%)
620610% - Genmed Commercial Finance Limited
71.4% - Industry AVG
GENMED COMMERCIAL FINANCE LIMITED financials

Genmed Commercial Finance Limited's latest turnover from December 2023 is estimated at £5.1 million and the company has net assets of -£19.8 million. According to their latest financial statements, we estimate that Genmed Commercial Finance Limited has 9 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 16,126 | 82,418 | 736 | ||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 6,083 | 48,025 | 547 | ||||||||||||
Gross Profit | 10,043 | 34,393 | 189 | ||||||||||||
Admin Expenses | 534,665 | 553,597 | 614,943 | 719,645 | |||||||||||
Operating Profit | -301,389 | -325,121 | -558,068 | -534,665 | -543,554 | -580,550 | -719,456 | ||||||||
Interest Payable | 20,463 | 12 | 3,561 | ||||||||||||
Interest Receivable | 3 | ||||||||||||||
Pre-Tax Profit | -321,852 | -325,121 | -558,068 | -534,665 | -543,554 | -580,562 | -723,014 | ||||||||
Tax | |||||||||||||||
Profit After Tax | -321,852 | -325,121 | -558,068 | -534,665 | -543,554 | -580,562 | -723,014 | ||||||||
Dividends Paid | |||||||||||||||
Retained Profit | -321,852 | -325,121 | -558,068 | -534,665 | -543,554 | -580,562 | -723,014 | ||||||||
Employee Costs | 68,475 | 66,845 | 66,437 | 75,107 | 81,601 | 73,084 | 51,215 | ||||||||
Number Of Employees | 2 | 2 | 3 | 2 | 2 | ||||||||||
EBITDA* | -300,448 | -234,597 | -240,448 | -216,869 | -225,667 | -263,601 | -406,416 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1 | 2 | 2 | 670 | 1,337 | 2,318 | 3,076 | 4,016 | 4,955 | 5,896 | 96,420 | 413,711 | 730,508 | 1,042,825 | 1,354,032 |
Intangible Assets | |||||||||||||||
Investments & Other | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 2 | 2 | 2 | 670 | 1,337 | 2,318 | 3,076 | 4,016 | 4,956 | 5,897 | 96,421 | 413,712 | 730,509 | 1,042,826 | 1,354,033 |
Stock & work in progress | 4,075 | ||||||||||||||
Trade Debtors | 3,187 | 3,352 | 2,487 | 4,887 | 2,087 | 2,384 | 865 | 81,437 | |||||||
Group Debtors | |||||||||||||||
Misc Debtors | 38,371 | 26,106 | 6,782 | 24,268 | 160,309 | 159,344 | 33,920 | ||||||||
Cash | 48,550 | 12,991 | 63,297 | 7,599 | 22,536 | 17,555 | 136,957 | ||||||||
misc current assets | |||||||||||||||
total current assets | 3,187 | 3,352 | 2,487 | 4,887 | 2,087 | 2,384 | 865 | 81,437 | 86,921 | 39,097 | 70,079 | 31,867 | 182,845 | 176,899 | 174,952 |
total assets | 3,189 | 3,354 | 2,489 | 5,557 | 3,424 | 4,702 | 3,941 | 85,453 | 91,877 | 44,994 | 166,500 | 445,579 | 913,354 | 1,219,725 | 1,528,985 |
Bank overdraft | 31 | 405 | |||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 19,791,254 | 19,791,169 | 19,684,453 | 19,569,978 | 19,507,384 | 19,345,659 | 19,264,853 | ||||||||
Group/Directors Accounts | 15,365,405 | 18,407,085 | 18,559,379 | 18,256,947 | 18,200,389 | 17,937,405 | 17,686,334 | ||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 3,776,818 | 366,403 | 10,463 | 33,937 | 23,603 | 48,999 | 29,173 | ||||||||
total current liabilities | 19,791,254 | 19,791,169 | 19,684,453 | 19,569,978 | 19,507,384 | 19,345,659 | 19,264,853 | 19,142,223 | 18,773,488 | 18,569,873 | 18,290,884 | 18,223,992 | 17,986,809 | 17,715,507 | |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 19,623,955 | ||||||||||||||
provisions | |||||||||||||||
total long term liabilities | 19,623,955 | ||||||||||||||
total liabilities | 19,791,254 | 19,791,169 | 19,684,453 | 19,569,978 | 19,623,955 | 19,507,384 | 19,345,659 | 19,264,853 | 19,142,223 | 18,773,488 | 18,569,873 | 18,290,884 | 18,223,992 | 17,986,809 | 17,715,507 |
net assets | -19,788,065 | -19,787,815 | -19,681,964 | -19,564,421 | -19,620,531 | -19,502,682 | -19,341,718 | -19,179,400 | -19,050,346 | -18,728,494 | -18,403,373 | -17,845,305 | -17,310,638 | -16,767,084 | -16,186,522 |
total shareholders funds | -19,788,065 | -19,787,815 | -19,681,964 | -19,564,421 | -19,620,531 | -19,502,682 | -19,341,718 | -19,179,400 | -19,050,346 | -18,728,494 | -18,403,373 | -17,845,305 | -17,310,638 | -16,767,084 | -16,186,522 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -301,389 | -325,121 | -558,068 | -534,665 | -543,554 | -580,550 | -719,456 | ||||||||
Depreciation | 941 | 90,524 | 317,620 | 317,796 | 317,887 | 316,949 | 313,040 | ||||||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | -4,075 | 4,075 | |||||||||||||
Debtors | -165 | 865 | -2,400 | 2,800 | -297 | 1,519 | -80,572 | 43,066 | 12,265 | 19,324 | -17,486 | -136,041 | 965 | 125,424 | 33,920 |
Creditors | 85 | 106,716 | 114,475 | 19,569,978 | -19,507,384 | 161,725 | 80,806 | 19,264,853 | |||||||
Accruals and Deferred Income | -3,776,818 | 3,410,415 | 355,940 | -23,474 | 10,334 | -25,396 | 19,826 | 29,173 | |||||||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | 3,097,702 | 102,019 | -246,436 | -70,494 | -252,028 | -365,124 | -415,238 | ||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 1 | -1 | 1 | ||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -15,365,405 | -3,041,680 | -152,294 | 302,432 | 56,558 | 262,984 | 251,071 | 17,686,334 | |||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | -19,623,955 | 19,623,955 | |||||||||||||
share issue | |||||||||||||||
interest | -20,463 | -12 | -3,558 | ||||||||||||
cash flow from financing | -3,062,143 | -152,294 | 56,556 | 262,984 | 251,059 | 2,219,268 | |||||||||
cash and cash equivalents | |||||||||||||||
cash | -48,550 | 35,559 | -50,306 | 55,698 | -14,937 | 4,981 | -119,402 | 136,957 | |||||||
overdraft | -31 | 31 | -405 | 405 | |||||||||||
change in cash | -48,550 | 35,559 | -50,275 | 55,667 | -14,937 | 5,386 | -119,807 | 136,957 |
genmed commercial finance limited Credit Report and Business Information
Genmed Commercial Finance Limited Competitor Analysis

Perform a competitor analysis for genmed commercial finance limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mid companies, companies in W14 area or any other competitors across 12 key performance metrics.
genmed commercial finance limited Ownership
GENMED COMMERCIAL FINANCE LIMITED group structure
Genmed Commercial Finance Limited has no subsidiary companies.
Ultimate parent company
GENERAL MEDITERRANEAN HOLDING SA
#0009492
2 parents
GENMED COMMERCIAL FINANCE LIMITED
02426578
genmed commercial finance limited directors
Genmed Commercial Finance Limited currently has 2 directors. The longest serving directors include Mr Arif Husain (Sep 1992) and Mr Tameem Auchi (Oct 2006).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Arif Husain | England | 79 years | Sep 1992 | - | Director |
Mr Tameem Auchi | 47 years | Oct 2006 | - | Director |
P&L
December 2023turnover
5.1m
+135%
operating profit
-15m
0%
gross margin
13.7%
-13.29%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-19.8m
0%
total assets
3.2k
-0.05%
cash
0
0%
net assets
Total assets minus all liabilities
genmed commercial finance limited company details
company number
02426578
Type
Private limited with Share Capital
industry
64999 - Other financial service activities, except insurance and pension funding, (not including security dealing on own account and factoring) n.e.c.
incorporation date
September 1989
age
36
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
drayshire limited (November 1989)
accountant
-
auditor
-
address
lincoln house, 137-143 hammersmith road, london, W14 0QL
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
genmed commercial finance limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to genmed commercial finance limited. Currently there are 0 open charges and 1 have been satisfied in the past.
genmed commercial finance limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GENMED COMMERCIAL FINANCE LIMITED. This can take several minutes, an email will notify you when this has completed.
genmed commercial finance limited Companies House Filings - See Documents
date | description | view/download |
---|